403 results
Page 2 of 21
8-K
EX-99.1
t5onhjeohu7ds65
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
EX-99.1
32axvari5z5wsdfcv
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
EX-99.1
826i21
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
7:40am
8-K
nhlelg6xjbejdjp jc
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm
8-K
EX-2.1
f7aeck6
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm
8-K
EX-99.1
xddc16n68h7t 66ypm
9 Nov 22
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
4:07pm
8-K
EX-99.1
nxg32135whs1iccqew0
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:59am
8-K
EX-99.1
e49 eu06nxfsyq8lnvc
3 Aug 22
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
4:07pm
DEFA14A
vc0iw5qolwav7qia
7 Jul 22
Additional proxy soliciting materials
4:18pm